These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25920510)

  • 41. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience.
    Wu H; Zhang L; Shao H; Sokol L; Sotomayor E; Letson D; Bui MM
    Br J Haematol; 2014 Jul; 166(1):60-8. PubMed ID: 24673481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
    Staples WG; Gétaz EP
    S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Staging and evaluation of bone marrow involvement in lymphoma].
    Miyauchi J; Matsumoto K
    Nihon Rinsho; 2014 Mar; 72(3):456-61. PubMed ID: 24724403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
    Zhang QY; Foucar K
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan.
    Sultan S; Irfan SM; Parveen S; Haider SA; Masood M
    Asian Pac J Cancer Prev; 2016; 17(4):1857-9. PubMed ID: 27221865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of histology of bone marrow trephine in malignant lymphomas.
    Durosinmi MA; Mabayoje VO; Akinola NO
    Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab.
    Gaudio F; Giordano A; Perrone T; Pastore D; Curci P; Delia M; Napoli A; de' Risi C; Spina A; Ricco R; Liso V; Specchia G
    Acta Haematol; 2011; 126(1):44-51. PubMed ID: 21430371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
    Ebie N; Loew JM; Gregory SA
    Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Bad risk" non-Hodgkin lymphomas.
    Horwich A; Peckham M
    Semin Hematol; 1983 Jan; 20(1):35-56. PubMed ID: 6342140
    [No Abstract]   [Full Text] [Related]  

  • 52. The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study).
    Govi S; Christie D; Mappa S; Marturano E; Bruno-Ventre M; Messina C; Medina EA; Porter D; Radford J; Heo DS; Park Y; Pro B; Jayamohan J; Pavlakis N; Zucca E; Gospodarowicz M; Ferreri AJ;
    Leuk Lymphoma; 2014 Aug; 55(8):1796-9. PubMed ID: 24295130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry.
    Sorigue M; Cañamero E; Miljkovic MD
    Blood Rev; 2021 May; 47():100778. PubMed ID: 33187810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoma in Adolescents and Young Adults.
    Brugières L; Brice P
    Prog Tumor Res; 2016; 43():101-14. PubMed ID: 27595360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials.
    Rutherford SC; Li V; Ghione P; Chen Z; Martin P; Leonard JP
    Br J Haematol; 2017 Oct; 179(2):242-245. PubMed ID: 28677889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Massive bone marrow necrosis revealing an HIV-related primary bone marrow lymphoma: a diagnostic challenge.
    Diamantidis MD; Gogou V; Koletsa T; Metallidis S; Papaioannou M
    Int J Hematol; 2019 Jan; 109(1):125-129. PubMed ID: 30293217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discrepancies in quantitative assessment of bone marrow involvement in lymphoma: do they reflect specialized micro-environmental cellular niches and cell-stromal interactions?
    Katz BZ; Polliack A
    Leuk Lymphoma; 2006 Sep; 47(9):1730-1. PubMed ID: 17064979
    [No Abstract]   [Full Text] [Related]  

  • 58. Localized non-Hodgkin's Lymphoma.
    Timothy AR; Lister TA; Katz D; Jones AE
    Eur J Cancer (1965); 1980 Jun; 16(6):799-807. PubMed ID: 7408929
    [No Abstract]   [Full Text] [Related]  

  • 59. Malignant lymphomas of follicular center cell origin in man. III. Prognostic features.
    Stein RS; Cousar J; Flexner JM; Graber SE; McKee LC; Krantz S; Collins RC
    Cancer; 1979 Dec; 44(6):2236-43. PubMed ID: 116763
    [No Abstract]   [Full Text] [Related]  

  • 60. Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma.
    Nishimura K; Ota R; Mikajiri Y; Takahashi K; Sugishima S; Eto T
    Int J Lab Hematol; 2018 Feb; 40(1):34-40. PubMed ID: 28876549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.